These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33909918)

  • 1. Neuron-intrinsic origin of hyperexcitability during early pathogenesis of Alzheimer's disease: An Editorial Highlight for "Hippocampal hyperactivity in a rat model of Alzheimer's disease" on https://doi.org/10.1111/jnc.15323.
    Lee-Liu D; Gonzalez-Billault C
    J Neurochem; 2021 Aug; 158(3):586-588. PubMed ID: 33909918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal hyperactivity in a rat model of Alzheimer's disease.
    Sosulina L; Mittag M; Geis HR; Hoffmann K; Klyubin I; Qi Y; Steffen J; Friedrichs D; Henneberg N; Fuhrmann F; Justus D; Keppler K; Cuello AC; Rowan MJ; Fuhrmann M; Remy S
    J Neurochem; 2021 Jun; 157(6):2128-2144. PubMed ID: 33583024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.
    Busche MA; Chen X; Henning HA; Reichwald J; Staufenbiel M; Sakmann B; Konnerth A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8740-5. PubMed ID: 22592800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRE1 signaling exacerbates Alzheimer's disease pathogenesis.
    Duran-Aniotz C; Cornejo VH; Espinoza S; Ardiles ÁO; Medinas DB; Salazar C; Foley A; Gajardo I; Thielen P; Iwawaki T; Scheper W; Soto C; Palacios AG; Hoozemans JJM; Hetz C
    Acta Neuropathol; 2017 Sep; 134(3):489-506. PubMed ID: 28341998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial toxic effects of Aβ through mitofusins in the early pathogenesis of Alzheimer's disease.
    Wu Z; Zhu Y; Cao X; Sun S; Zhao B
    Mol Neurobiol; 2014 Dec; 50(3):986-96. PubMed ID: 24710686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.
    Do Carmo S; Crynen G; Paradis T; Reed J; Iulita MF; Ducatenzeiler A; Crawford F; Cuello AC
    Mol Neurobiol; 2018 Apr; 55(4):3451-3476. PubMed ID: 28502044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer's disease.
    Kloskowska E; Pham TM; Nilsson T; Zhu S; Oberg J; Codita A; Pedersen LA; Pedersen JT; Malkiewicz K; Winblad B; Folkesson R; Benedikz E
    J Cell Mol Med; 2010 Jun; 14(6B):1816-23. PubMed ID: 19538474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease.
    Kobro-Flatmoen A; Nagelhus A; Witter MP
    Neurobiol Dis; 2016 Sep; 93():172-83. PubMed ID: 27195475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model.
    Frazzini V; Guarnieri S; Bomba M; Navarra R; Morabito C; Mariggiò MA; Sensi SL
    Cell Death Dis; 2016 Feb; 7(2):e2100. PubMed ID: 26890139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry of Alzheimer's disease amyloid plaques.
    Fraser PE; Lévesque L; McLachlan DR
    Clin Biochem; 1993 Oct; 26(5):339-49. PubMed ID: 8299204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.